Company profile: Mitotyping Technologies
1.1 - Company Overview
Company description
- Provider of forensic DNA analysis services for the criminal justice system, forensic laboratories, and anthropological applications, including mitochondrial DNA testing from small samples such as 2mm hair fragments or single teeth.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mitotyping Technologies
Pangaea Oncology
HQ: Spain
Website
- Description: Provider of precision oncology and personalized medicine based on genetic analysis for cancer patients, offering molecular diagnostics across cancer types, clinical trials services, biomarker discovery, companion diagnostics (DX) platform validation, preclinical research and diagnostics, in-vitro drug/vaccine testing, and multiplex assays in non-blood biological fluids for diagnostic and predictive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pangaea Oncology company profile →
Circulomics
HQ: United States
Website
- Description: Provider of micro- and nanotechnology-driven solutions for nucleic acid sample preparation and long-read sequencing, offering Nanobind high molecular weight DNA extraction from plant, animal, and microbial samples, library preparation protocols, services for single chromosomal genome assemblies, and applications leveraging optical mapping for genome structure analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circulomics company profile →
Sense Biodetection
HQ: United Kingdom
Website
- Description: Provider of molecular diagnostics, developing novel, user-centered handheld tests for infections and oncology, including Veros COVID-19, an instrument-free rapid COVID-19 test delivering results in about 15 minutes at the point of care without the need for specialized laboratory equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sense Biodetection company profile →
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
Frugi Bio
HQ: United States
Website
- Description: Provider of modular, paper-based, secure diagnostics for viral outbreak management using synthetic biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frugi Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mitotyping Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mitotyping Technologies
2.2 - Growth funds investing in similar companies to Mitotyping Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mitotyping Technologies
4.2 - Public trading comparable groups for Mitotyping Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →